SEED stands for the Study to Explore Early Development. SEED is the largest epidemiological study to-date designed to compare children with autism and other developmental delays to children without these delays. The first phase of this study (SEED I) began in 2006. We enrolled over 3700 children. The second phase (SEED II) began in 2012 and we enrolled an additional 3300 children. The third phase, SEED 3, began in 2016 and will enroll another 3300 children. Results from SEED will help researchers to better understand the health and behavior of young children with autism and to identify factors that contribute to autism.

pexels-photo-87324SEED is funded by the Centers for Disease Control and Prevention (CDC) as part of the Centers for Autism and Developmental Disabilities Research and Epidemiology Network (CADDRE).

We are currently seeking families from central North Carolina to participate in SEED 3. You can learn if your family might be eligible by browsing this website and completing the Interest Form or you may contact us by phone or email.

Contact Us

Phone, toll-free: 1.866.633.8003
Fax: 919.843.0568
Email